Sign in

CIK 0001980845 · Non-accelerated filer<br>Smaller reporting company<br>Emerging growth company

enGene Therapeutics Inc.

Sign in to watch
Ticker
ENGN
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Oct 31
Incorporated
Canada (Federal Level)
Entity type
operating
Phone
(514) 332-4888
Business address
4868 RUE LEVY, SUITE 220, SAINT-LAURENT, Quebec, Canada
Former names
enGene Holdings Inc.

Securities

  • ENGN Common Stock Nasdaq
  • ENGNW Warrants Nasdaq
  1. 3 Insider Initial Statement of Ownership
  2. 3 Insider Initial Statement of Ownership
  3. 3 Insider Initial Statement of Ownership
  4. 3 Insider Initial Statement of Ownership
  5. 3 Insider Initial Statement of Ownership
  6. 3 Insider Initial Statement of Ownership
  7. 3 Insider Initial Statement of Ownership
  8. 3 Insider Initial Statement of Ownership
  9. 8-K Event Material agreement · Acquisition or sale completed · Unregistered share sale · Shareholder rights changed · Change in control · Executive or director change · Bylaws or fiscal year change · Code of ethics change · Shell status change
  10. CERT Other Certification
  11. 8-A12B Other Registration of Securities
  12. 425 Deal Prospectus/Communication re Business Combination
  13. 424B3 Offering Prospectus
  14. SEC STAFF LETTER Other SEC Staff Letter Redacted Exhibit
  15. EFFECT Other Notice of Effectiveness
  16. CORRESP Other Correspondence Between Filers and SEC Staff
  17. S-4/A Deal Registration Statement - Business Combination
  18. CORRESP Other Correspondence Between Filers and SEC Staff
  19. 425 Deal Prospectus/Communication re Business Combination
  20. UPLOAD Other SEC-generated Letter

Page 13 of 14 · 268 filings